Top CIO Executive Search Firm in New Delhi for Pharma & Biotech — 2026

New Delhi and the NCR are the corporate headquarters of several of India's largest pharmaceuticals majors and a deep formulations, vaccines and healthcare-products base. The pharma technology-leadership seat here is frequently an enterprise and global-digital CIO role: the leader owns the global, validated, GxP-compliant digital estate, the commercial and supply-chain technology that runs international markets, the data and AI agenda reshaping R&D and commercial, and the cyber and data-integrity posture that regulators and the board demand. The defining scarcity is the technology leader who can run a global, validated and regulated estate while driving the digital-and-data transformation of a scaled pharma business. The failure mode is a plant-IT leader who cannot operate globally and at board level, or a digital leader with no GxP and data-integrity fluency.

The search is calibrated to the global, regulated reality. Compensation is cash-led with performance pay and long-term incentives or equity in listed pharma majors, and more equity-led in biotech. The brief sets which applies. The stakeholder map runs from the CEO, board and global commercial, manufacturing and R&D leadership to regulators. References reach to global business and quality leaders, because the question that decides these mandates — can this leader run a global validated estate and drive transformation — is answered by those who have watched it deliver across markets.